ribosepharm Overview

  • Founded
  • 1983
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

ribosepharm General Information

Description

Wholesaler and distributor of medicines for cancer treatment. The company specializes in medicines for colorectal tumors and hematological diseases.

Contact Information

Formerly Known As
ribopharm
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors (Healthcare)
Parent Company
Primary Office
  • Lochhamer Schlag 17
  • 82166 Gräfelfing
  • Germany
+49 089 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ribosepharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ribosepharm‘s full profile, request access.

Request a free trial

ribosepharm Executive Team (1)

Name Title Board Seat Contact Info
Jens Wartmannn Chief Executive Officer
To view ribosepharm’s complete executive team members history, request access »

ribosepharm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ribosepharm‘s full profile, request access.

Request a free trial